Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Stronger antiplatelet after heart attacks. | Antiplatelet used after stents, heart attacks and strokes. |
| Body system | Blood & Clotting | Blood & Clotting |
| Drug class | Antiplatelets | Antiplatelets |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | After heart attack (with aspirin), Long-term prevention after heart attack (lower dose), Some strokes and TIAs | After heart attack or stent (with aspirin), Stroke and TIA prevention, Peripheral artery disease |
| How it works | Blocks platelets from clumping, directly and reversibly. | Stops platelets clumping together to form clots. |
| Starts working | — | — |
| Half-life | About 7 hours | About 6 hours (effect lasts the platelet's 7–10 day lifespan) |
| Typical adult dose | 180 mg loading dose, then 90 mg twice a day for 12 months; 60 mg twice a day long term in some. | 75 mg once a day (300–600 mg loading dose). |
| Forms | Tablet, Orodispersible tablet | Tablet |
| Common side effects | Shortness of breath, Bruising, Nosebleeds | Bruising, Nosebleeds, Diarrhoea |
| Serious side effects | Major bleeding, Slow heart pauses | Major bleeding, TTP (rare blood disorder) |
| Don't take if | — | Active bleeding; Severe liver impairment; Taking omeprazole or esomeprazole (reduces effect) |
| Alcohol | — | Best to limit. Alcohol raises bleeding risk. |
| Pregnancy | Use with cautionNot recommended; limited data. | Use with cautionLimited data; used if essential. |
| Breastfeeding | — | Use with cautionLimited data; acceptable if needed. |
| In use since | 2010 | 1997 |
| Brand names | United States: BrilintaUnited Kingdom: BriliqueIndia: Brilinta, Axcer | United States: PlavixUnited Kingdom: PlavixIndia: Clopilet, Deplatt, Clavix |
| Legal status | — | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | B01AC24 | B01AC04 |
Taken together
- ModerateTicagrelor + Clopidogrel: Dual antiplatelet therapy
Two antiplatelets increase bleeding, but this is often intentional for months after a heart attack or stent.